Search Results - Urtenova, Magaripa A

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Predictive markers of response to immune checkpoint inhibitor rechallenge in metastatic non-small cell lung cancer

    Predictive markers of response to immune checkpoint inhibitor rechallenge in metastatic non-small cell lung cancer by Musaelyan, Aram A, Odintsova, Svetlana V, Musaelyan, Karina A, Urtenova, Magaripa A, Solovyova, Ekaterina P, Menshikova, Lyubov I, Orlov, Sergey V

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Rapid Improvement of the Performance Status and Reduction of the Tumor Size in KRAS-Mutated Colorectal Cancer Patient Receiving Binimetinib, Hydroxychloroquine, and Bevacizumab

    Rapid Improvement of the Performance Status and Reduction of the Tumor Size in KRAS-Mutated Colorectal Cancer Patient Receiving Binimetinib, Hydroxychloroquine, and Bevacizumab by Orlov, Sergey V., Urtenova, Magaripa A., Sviridenko, Maria A., Nesterov, Denis V., Sokolova, Tatiana N., Imyanitov, Evgeny N.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Clinical predictors of response to single‑agent immune checkpoint inhibitors in chemotherapy‑pretreated non‑small cell lung cancer

    Clinical predictors of response to single‑agent immune checkpoint inhibitors in chemotherapy‑pretreated non‑small cell lung cancer by Musaelyan, Aram A, Moiseyenko, Fedor V, Emileva, Tancholpon E, Oganesyan, Ani P, Oganyan, Karina A, Urtenova, Magaripa A, Odintsova, Svetlana V, Chistyakov, Ivan V, Degtyarev, Alexey M, Akopov, Andrey L, Imyanitov, Evgeny N, Orlov, Sergey V

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Rapid Improvement of the Performance Status and Reduction of the Tumor Size in KRAS-Mutated Colorectal Cancer Patient Receiving Binimetinib, Hydroxychloroquine, and Bevacizumab

    Rapid Improvement of the Performance Status and Reduction of the Tumor Size in KRAS-Mutated Colorectal Cancer Patient Receiving Binimetinib, Hydroxychloroquine, and Bevacizumab by Orlov, Sergey V, Urtenova, Magaripa A, Sviridenko, Maria A, Nesterov, Denis V, Sokolova, Tatiana N, Imyanitov, Evgeny N

    Get full text
    Report
    Save to List
    Saved in:

Search Tools: